Out-of-specification (OOS) results were found for atomoxetine content in reference samples of several batches and a failure in the capsule mass uniformity parameter, caused among others by loss of active substance during filling and lack of full capsule weight control. Potential effects: reduced treatment effectiveness, possible worsening of disease symptoms.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Konaten (Atomoxetine) from the listed batches; check the batch number on the package; if you possess the product, return it to a pharmacy and consult a doctor or pharmacist if in doubt.
The Chief Pharmaceutical Inspector withdrew the specified batches from the market nationwide, prohibited their further placing on the market and granted the decision immediate enforceability; the manu...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related